Literature DB >> 16133148

Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.

Shunsuke Miyai1, Shinichi Yoshimura, Yasumasa Iwasaki, Susumu Takekoshi, Ricardo V Lloyd, Robert Yoshiyuki Osamura.   

Abstract

The functional development of pituitary cells depends on the expression of a combination of transcription factors and co-factors. Pituitary-specific transcription factor-1 (Pit-1) is required for the expression of growth hormone (GH), prolactin (PRL), and the thyroid-stimulating hormone beta subunit (TSH beta) and acts synergistically with the estrogen receptor (ER) and GATA-binding protein 2 (GATA-2) to induce PRL and TSH beta expression, respectively. The glycoprotein hormone alpha subunit (alpha SU) is the first hormone to be expressed during pituitary development. In addition to being expressed in follicle-stimulating hormone, luteinizing hormone (LH), and TSH cells, alpha SU is reported to co-localize with GH in pituitary cells. These findings have led to the suggestion that the expression of Pit-1 in cells of the alpha SU-based gonadotropin cell lineage might also lead to the expression of GH. In this study, we transfected HP 75 cells (derived from a human non-functioning pituitary adenoma that expressed alpha SU and LH beta) with Pit-1 by using an adenovirus FLAG-Pit-1 construct. Most of the transfected cells expressed GH mRNA, with fewer cells expressing PRL and TSH beta mRNA. The HP 75 cells expressed the genes for ER and GATA-2, thus allowing their expression of GH, PRL, and TSH beta mRNA in response to Pit-1. These results support the hypothesis that GH can be induced in cells that possess an active alpha SU gene and shed light on the basic molecular mechanism that drives the development of GH, PRL, and TSH beta expression in the alpha SU-based gonadotroph lineage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133148     DOI: 10.1007/s00441-005-0033-z

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  5 in total

1.  Pathology, pathogenesis and therapy of growth hormone (GH)-producing pituitary adenomas: technical advances in histochemistry and their contribution.

Authors:  Robert Y Osamura; Noboru Egashira; Hanako Kajiya; Mao Takei; Maya Tobita; Takashi Miyakoshi; Chie Inomoto; Susumu Takekoshi; Akira Teramoto
Journal:  Acta Histochem Cytochem       Date:  2009-08-11       Impact factor: 1.938

2.  Is it time to consider the expression of specific-pituitary hormone genes when typifying pituitary tumours?

Authors:  Araceli García-Martínez; Johana Sottile; Carmen Fajardo; Pedro Riesgo; Rosa Cámara; Juan Antonio Simal; Cristina Lamas; Hernán Sandoval; Ignacio Aranda; Antonio Picó
Journal:  PLoS One       Date:  2018-07-06       Impact factor: 3.240

3.  Seasonal differences in the transcriptome profile of the Zhedong white goose (Anser cygnoides) pituitary gland.

Authors:  Wanqiu Zhao; Taoyan Yuan; Yan Fu; Dong Niu; Weihu Chen; Li Chen; Lizhi Lu
Journal:  Poult Sci       Date:  2020-11-03       Impact factor: 3.352

Review 4.  Pathology of the human pituitary adenomas.

Authors:  Robert Y Osamura; Hanako Kajiya; Mao Takei; Noboru Egashira; Maya Tobita; Susumu Takekoshi; Akira Teramoto
Journal:  Histochem Cell Biol       Date:  2008-08-08       Impact factor: 4.304

5.  The PIT1 gene polymorphisms were associated with chicken growth traits.

Authors:  Qinghua Nie; Meixia Fang; Liang Xie; Min Zhou; Zhangmin Liang; Ziping Luo; Guohuang Wang; Wensen Bi; Canjian Liang; Wei Zhang; Xiquan Zhang
Journal:  BMC Genet       Date:  2008-02-27       Impact factor: 2.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.